CCM
CEMI

Cadence Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Cadence Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$201K Sell
41,293
-136,738
-77% -$648K 0.05% 270
2020
Q2 		$579K Buy
+178,031
New +$1.69M 0.08% 301

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cadence Capital Management's CEMI Position: Q3 2020 in Review

Cadence Capital Management reduced its Chembio diagnostics, Inc. (CEMI) stake by 77% in Q3 2020, selling an estimated $648K and leaving 41,293 shares worth $201K. The position accounts for 0.05% of the portfolio, ranked #270.

Cadence Capital Management first reported a position in CEMI in Q2 2020 and has held it in 2 quarters since. The position peaked at $579K in Q2 2020. 59 funds tracked by Wall St. Rank hold CEMI as of Q3 2020.

  • Cadence Capital Management held 41,293 shares of Chembio diagnostics, Inc. worth $201K as of Q3 2020.
  • Cadence Capital Management sold 136,738 Chembio diagnostics, Inc. shares in Q3 2020, an estimated $648K.
  • Chembio diagnostics, Inc. made up 0.05% of Cadence Capital Management's portfolio in Q3 2020, its #270 holding.
  • Cadence Capital Management first reported a position in Chembio diagnostics, Inc. in Q2 2020 and has held it in 2 quarters since.
  • Cadence Capital Management's Chembio diagnostics, Inc. position peaked at $579K in Q2 2020.
  • 59 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.